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1. Introduction 
The value of prostatic sonography has dramatically increased in the past three decades. 
Transrectal ultrasound (TRUS) imaging is currently an integral part of prostate cancer 
diagnosis and treatment procedures, providing high-resolution anatomical detail of the 
prostate region. In this chapter we review the anatomy and sonographic methods in 
imaging of the prostate and prostatic diseases. Also we emphasize the role of new 
sonographic techniques, such as color and power Doppler, the use of contrast agents, 3D 
sonography and elastography for diagnosis of different prostate diseases especially prostate 
cancer. We also discuss the use of systematic and targeted sonographic-guided biopsies as 
gold standard for prostate cancer detection. Finally, we will elaborate the new role of 
ultrasound in management of prostate cancer.   
2. Anatomy of the prostate 
2.1 Embryology of the prostate 
In the 4th week of gestation, the urogenital septum divides the cloaca into two parts: The 
rectum posteriorly and the primitive urogenital sinus anteriorly. In the 5th week, the distal 
portions of the Wolffian canal and the Mullerian canal attach to the posterior aspect of the 
primitive urogenital sinus (Fig. 1) to form an elevation called Mullerian tubercle. The 
tubercle divides the primitive urogenital sinus into vesico-urethral canal superiorly and 
definitive urogenital sinus inferiorly.The Wolffian canal forms the vas deferens, the ampulla 
of the vas and the seminal vesicle. The Mullerian canal regresses to form the utricle. 
Formation of the prostate begins at the 10th week of gestation by proliferation of the 
epithelium of the posterior urethra around the orifices of the Wolffian canal, to surround the 
urethral circumference. The prostatic glands formed anterior to the urethra regress and are 
replaced by fibromuscular stroma. The secretory function of the glands starts about the 13th 
week of gestation. (Brandes, 1989). 
2.2 Gross anatomy of the prostate and its relations  
The term “prostate”  was originally derived from the Greek word “prohistani” , meaning “to 
stand in front” , and has been used to describe the organ located in front of the urinary 
bladder (Lowsley, 1912). The prostate is conical in shape with its long axis directed 
www.intechopen.com
 Sonography 
 
46 
inferiorly and anteriorly. The shape and size of the prostate may vary with age. The prostate 
of an adult man measures 20 – 25 gms in weight. The base of the prostate is directed 
superiorly and in contact with the bladder base. The apex is directed inferiorly and in 
contact with the external sphincter above the deep fascia of the urogenital membrane. The 
anterior border is separated from the symphysis pubis and pubic bones by the retropubic 
space which contains loose areolar tissue, preprostatic venous plexus, lymphatics, nerves 
and puboprostatic ligament. The trapezoid area is an extraprostatic area of anatomic 
weakness. It may be involved by carcinoma extending through the inferior neurovascular 
pedicle. This area bounded by the prostate proximally, the rectourethralis muscle distally, 
the membranous urethra anteriorly and the rectum posteriorly (Mayers et al, 1987). 
Posteriorly, the prostate is related to the rectum and is separated from it by the Denoviller’s 
fascia which extends superiorly, behind the seminal vesicles up to the peritoneal reflection. 
At each posterolateral aspect of the prostate, the hypogastric pelvic fascia contains the 
neurovascular bundle of the prostate, seminal vesicles and bladder neck (Fig. 2). 
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Fig. 1. The embryological origin and development of the prostatic urethra and the prostate 
(adapted from Delmas, 1991) 
 
Fig. 2. Relations of the prostate in the coronal (A) and sagittal planes (B) 
2.3 The distal seminal tract 
It is formed of two seminal vesicles, ampullae of the vasa differentia and ejaculatory ducts. 
The seminal vesicle is a cystic structure, measuring about 35 mm in length and 15 mm in 
width. It is related anteriorly to the urinary bladder and posteriorly to the the rectum.The 
ampula of the vas is located medial to the seminal vesicle. The vassal ampula joins the 
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seminal vesicle to form the ejaculatory duct. Each duct enters the base of the prostate, passes 
through central zone to end in the urethra below the utricle (Brandes, 1989).  
2.4 Lobar concept of intraprostatic anatomy 
In 1912, Lowsley demonstrated the first detailed description of the anatomy of the prostate. 
This traditional concept which is no longer used, divided the prostate into lobes: an anterior, 
posterior, middle and two lateral lobes. This method has been used to identify the prostate 
and prostatic disease for about 60 years. The anterior lobe was situated from the anterior 
margin of the gland to the level of the prostatic urethra. The middle lobe was a small area 
between the proximal prostatic urethra and the ejaculatory ducts. This lobe extnds form the 
base of the prostate to the level of verumontanum. The posterior lobe was situated posterior 
to the ejaculatory ducts and extends to the posterior margin of the gland. The two lateral 
lobes extend from the lateral margin of the gland bilaterally toward the middle part of the 
gland. None of these lobes has clearly defined medial margin (Lowsley, 1912). 
2.5 Zonal concept of intraprostatic anatomy 
The understanding of the gross and microscopic anatomy of the prostate has changed 
during the past few decades. Since 1965, a zonal concept of anatomy has evolved initially 
developed by McNeal and then modified over about three decades. The prostate is best 
considered to be a fusion of different glandular regions contained within a discontinuous 
capsule (McNeal, 1968, 1988). The prostate is composed of four glandular regions and a non-
glandular region which is the anterior fibromuscular stroma (Fig. 3). The fibromuscular 
stroma (FMS) is the anteromedial portion of the gland is devoid of glandular tissue. This 
region is generally considered to be of less clinical significance. The peripheral zone (PZ) 
comprises the largest portion of the glandular prostate in young man (70%). The PZ is  
  
Fig. 3. Zonal anatomy of the prostate in coronal and sagittal planes showing the central zone 
(C), peripheral zone (P), transition zone (T) and anterior fibromuscular stroma (A). It also 
shows the distal seminal tract formed of the ampula of the vas deference (d) which joins the 
seminal vesicle (S) to form ejaculatory duct (e) which opens at vera montanium (v)   
(adapted from McNeal 1968) 
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situated posteriorly, posterolaterally and a thin layer of this tissue also extends up laterally 
and anterolaterally. Distal to the verumontanum, the PZ often surrounds the urethra and 
occupies the apical region if the prostate. The transition zone (TZ) is situated on both sides 
of the proximal prostatic urethra and comprises only 5 to 10% of the glandular tissue in the 
non hyperplastic prostate. The surgical capsule is an interface between the PZ and TZ. In the 
aging prostate where the TZ can show marked glandular hyperplasia and may constitute 
the majority of prostatic glandular elements. The periurethral glandular zone (PUG) consists 
of mucosal glands in the prostatic urethra itself and represents only a tiny fraction of the 
glandular prostate. This zone may become hyperplastic with age to form the “median lobe”  
which may obstruct the bladder neck. The central zone (CZ) is cone-shaped with its base 
forms the base of prostate, bordering the urinary bladder and seminal vesicles and its apex 
is at the verumontanum The CZ forms about 25% of the glandular prostatic tissue. The CZ 
surrounds the ejaculatory ducts throughout their entire courses in the prostate. The site 
where the ejaculatory ducts enter the CZ is devoid of prostatic capsule. The extraprostatic 
space invaginates around the ejaculatory ducts down to the verumontanum forming the 
“ invaginated extra prostatic space” . If the ejaculatory ducts are invaded by carcinoma, the 
tumor will have a ready “highway” to the seminal vesicles and extraprostatic space. 
2.6 Correlation of the lobar and zonal concepts of anatomy of the prostate 
A comparison of Lowsley lobar and McNeal zonal concepts of anatomy is possible and 
important to compare the clinical findings. Clinicians may still refer to lobar anatomy while 
radiologists use zonal anatomy. So, the anterior lobe correlates with the anterior fibro-
muscular stroma. The medial lobe and the CZ are similar. The sum of the posterior and two 
lateral lobes correlated to a large extent with the PZ. 
2.7 Correlation of the zonal anatomy and origin of prostatic diseases 
With the development of cross sectional – imaging studies like transrectal ultrasound 
(TRUS) and magnetic resonance imaging (MRI), the zonal concept of anatomy becomes 
useful technique to apply because the different areas can be definite (Rifkin et al, 1990). The 
zonal concept of anatomy is also useful because it incorporated a clearer understanding if 
the development of disease. The origin of prostatic disease was poorly understood under 
Lowsley’s concept of lobar anatomy. It was previously thought that cancer only arises in the 
posterior lobe and BPH develops predominantly in the lateral and, to a lesser degree in the 
median lobe. It is now understood that the prostate cancer develops in the acinar tissue 
predominantly the peripheral prostate. Although the PZ is three times larger in volume that 
the CZ, prostate cancer develops seven times more often in the PZ. It was shown that about 
50% of cancer arises in the anterior half of the prostate, including all those cancers from the 
TZ (20% of the total), CZ (10%) and anteriorly situated portions of the PZ. In contrast, BPH 
develops exclusively from the central gland, approximately 95% from the TZ and 5% from 
the periurethral glandular tissue. Prostatitis (when not due to surgical manipulation) starts 
mainly in the PZ similar to the prostatic cancer (McNeal et al 1988).  
3. Techniques and approaches of prostatic ultrasonography 
Ultrasonography is firmly established diagnostic tool in prostatic imaging. Recent 
development in US technology has led to significant improvements in image quality, 
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consistency and resolution. Additionally, dynamic scanners, color flow imaging and real 
time imaging have allowed appreciation of blood flow, reduced examination time and 
improved quality of the image. These advances combined with the portability, relative low 
cost and lack of risks of iodinated contrast media and irradiation have made US one of the 
most useful modality in evaluation of the prostate. Many approaches can be used to image 
the prostate as trans-abdominal, trans-urethral, trans-perineal and transrectal US. The 
common two approaches are transabdominal and transrectal ultrasound. 
3.1 Trans-abdominal ultrasound 
Transabdominal US of the prostate is nearly universally available and provides excellent 
anatomic information using the urine-filled bladder as an acoustic window. Prostate size, 
weight, shape and intravesical extent can be determined. Caudal angulation of the 
transducer to accommodate the public bone is often required. The normal prostate appears 
as a homogenous, round or ovoid structure with uniform low level echoes. The 
intraglandular zonal anatomy can not be visualized (Fig. 4). The relation between the 
prostate, bladder and seminal vesicles can be demonstrated (Abu-Yosef & Noryana 1982). 
 
Fig. 4. Transabdonal US of a moderately enlarged prostate in axial and sagittal planes 
3.2 Transrectal ultrasound (TRUS) 
In 1963, Takahashi and Ouchi were the first to describe the use of TRUS to evaluate the 
prostate. The first clinically applicable images of the prostate obtained with TRUS were 
described in 1967 by Watanabe et al, they used a 3.5 MHz transducer, which at that time was 
considered to be state of the art, to obtain images that were clinically meaningful. As US 
technology has become more refined, the use of TRUS in the evaluation of prostatic disease 
has increased. By the mid 1980s.TRUS had become a standard diagnostic instrument of the 
urologists and radiologists. Most investigators today prefer equipment using hand-held 
transducers which are available in frequencies ranging from 3.5 MHz up to 10 MHz with the 
optimum frequency being around 7.0 MHz. Transrectal probes are available in different 
sizes and shapes with diameters ranging from 1.2 to 2 cm. 
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4. Sonographic anatomy of the normal prostate 
Transrectal US of the prostate has revolutionized our ability to examine this organ. It 
provides excellent visualization of the prostate in the axial and sagittal planes.  
In the axial plane, scanning usually begins at a level just above the seminal vesicles and by 
sequential withdrawing of the transducer in a caudal direction, the base, mid gland and the 
apex is visualized (Fig. 5). When scanning the most cephalad areas, the vas deferens will be 
visualized. They will appear as bilateral round cystic structures. Then the seminal vesicles 
will come into view as the vas deferens joins with them superior to the prostate. They 
usually appear as bow-tie configuration, but they may be rounded, lobulated or flattened. 
At the level of the base of the prostate, the prostate appears as a symmetrical crescent-
shaped with triangular postero-lateral margin. The normal prostate will appear hyperechoic 
to the sminal vesicles and will have a homogenous echopattern. The CZ and TZ cannot be 
individually distinguished by their echogenicity. However the PZ appears more echogenic 
with homogenous echotexture. At the level of mid gland, the prostate becomes ovoid in 
shape. The anterior fibromuscular tissue is seem and has an echogenicity equal to or less 
than that of the glandular areas. The hypoechoic periurethral glandular tissue is 
demonstrated as hypoechoic area in the midline. Posterior and lateral to the PUG tissue, the 
PZ appears more echogenic and homogenous. The apex of the prostate appears more 
rounded. The obturator internus and levator anu muscles appear as hyperechoic structures 
lateral to the prostate apex. The prostate is surrounded by hyperegenic layer comprising the 
prostatic capsule and surrounding fat and fascia. The normal prostatic urethra is rarely 
visualized. The advantages of axial scanning include visualization of the left-right symmetry 
and echotexture,visualization of the anterior lateral portions of the PZ in a single view and 
assessment the lateral extracapsular spread of carcinoma (Rifkin, 1997). 
In the sagittal plane scanning starts in the midline where the entire prostate can be 
visualized in one image. The seminal vesicle will be superior and posterior to the base of the 
prostate, and the vas deferens will be seen anterior to the seminal vesicles. The seminal 
vesicles will be less echogenic than the prostate and will appear rounded in shape. In the 
midline sagittal plane, the hypoechoic periurethral tissue will be seen and may be difficult to 
differentiate form the anterior fibromuscular stroma. The rest of the prostate will be 
homogenous in echogenicity with the PZ slightly more echogenic than the CZ and TZ 
(fig. 6). By tilting the transducer slightly to the right or the left of midline, the lateral aspects 
of the prostate and seminal vesicles will be visualized. The lateral aspects of the prostate are 
normally more rounded and homogenous in ehcogenicity. The ejaculatory ducts can be 
identified as hypoechoic lines structures between two parallel echogenic lines as the course 
from the seminal vesicles through the CZ into prostatic urethra. The advantages of sagittal 
scanning include evaluation of the base and apex of the prostate in a single view, accurate 
measurement of the cranio-caudal diameter of the prostate or of a lesion within the prostate 
and better demonstration of the prostatic urethra and ejaculatory ducts ((Rifkin, 1997) 
Estimation of prostate volume may be useful in a variety of clinical settings. In cases of BPH, 
most urologists prefer to perform transurethral resections for glands under 60 grams, while 
open prostatectomy is preferred for glands over 60 grams (Narayan & Foster 1991). Other 
potential users include the comparison of the prostate volume with levels of PSA for early 
detection of the prostatic cancer. PSA density is an index calculated by dividing PSA by the 
volume of the prostate measured by TRUS. In absence of cancer, prostatic volume is directly  
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Fig. 5. TRUS axial images. (A) the level of distal seminal tract; showing seminal vesicle (SV) 
and vasl ampulla (V), (B) level of prostate base, (C) level of mid gland and (D) level of vera 
montanum showing its appearance as tour Eiffel 
 
Fig. 6. TRUS sagittal images; (A) in midline; (B ) in paramedical region; (C) peripheral part 
of the gland which is formed mainly of peripheral zone (PZ) and above it the body of 
seminal vesicle (SV) and (D) shows the confluence of vas and seminal vesicle (SV) to form 
the ejaculatory duct (arrowhead) 
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proportional to circulating serum PSA (Benson et al., 1992 ). Benign prostatic hyperplasia is 
associated with, on average, only 0.26 ng/ mL PSA per gram of tissue, whereas cancer 
results in a density 10-fold higher (Hammerer et al., 1995 ). Any PSA value greater than that 
predicted by gland volume should raise a suspicion of prostate cancer. Also, the pre-
treatment estimation of the volume of prostate cancer can provide important prognostic 
information after hormonal or radiation therapy. (Terris & Stamey 1991). The commonly 
used method in measuring prostate volume is the elliptical method. This formula can be 
transformed into volume = 0.523 x d1 x d2 x d3. Maximal width and height diameters are 
obtained at the largest appearing mid gland axial image section. The length dimension can 
be obtained on midline sagittal plane (Fig. 9). This method is widely used because it is easy 
and fast method. The fact that it is slightly less accurate than other methods is not 
documented (Terris & Stamey,1990).  
5. Diseases of the prostate and their sonographic appearance  
5.1 Cysts of the prostate 
Cysts of the prostate are confusing abnormalities because they are uncommon and their 
origin is uncertain. Small cysts are asymptomatic while large cysts may present with 
symptoms of urinary tract irritation, obstruction or hypofertility. The cysts may be 
complicated by infection, and stone formation. They may be turned malignant in about 
3% of cases (Litirup et al., 1988). The cysts are usually unilocular, sharply defined, thin 
walled and anechoic. They vary size from 0.5 cm to 3.0 cm in diameters (Fig. 7). Prostatic 
cysts are either midline prostatic cysts like utricle cyst and Mullerian duct cyst or lateral 
prostatic cysts as cysts of the ejaculatory ducts or acquired cysts which are associated with 
prostate cancer, PBH, and prostatic abscess (Patel et al., 2002). Utricle cysts are dilatation 
of the prostatic utricle which may be congenital (megautricle) or acquired due to 
obstruction of its orifice by inflammation (utriclocele). The utricle cysts are small 
intraprostatic midline cysts.. Mullerian duct cysts are remnants of Mullerian duct. These 
cysts are relatively large, extends superiorly and inferiorly from the level of the 
verumontanum even outside the prostate. Ejaculatory ducts cysts are present along the 
course of the ejaculatory ducts within the CZ. They are usually paramedian and 
unilateral. They are complex cysts with solid and cystic components.They containing 
spermatozoa. Extra-prostatic cysts are either cysts of the seminal vesicles or the ampulae 
of the vas. They are congenital in origin and associated with urinary tract anomalies. 
Some patients are manifested by obstructive azospermia and TRUS can classify the 
patients without cysts where TRUS-guided aspiration and seminal vesiculography can be 
performed and patients with cyst where TRUS-guided cyst aspiration and opacification 
can be performed (Donkol, 2010).  
5.2 Inflammatory diseases the prostate 
Acute prostatitis is acute bacterial inflammation of the prostate. The clinical diagnosis 
usually is not difficult. The patient has fever, perineal and low back pain; pain with 
defecation of after ejaculation; urethral discharge associated with dysuria, urgency, 
frequency, or retention. On examination, the prostate is swollen, boggy and tender. Griffiths 
and associates in 1984 described three characteristic sonographic features seen in a group of 
40 patients with an acute inflammation of the prostate as a periurethral echo-poor halo, a 
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prominent periprostatic venous plexus and hypoechoic areas within the prostate, 
predominantly in the peripheral zone (Griffiths et al., 1984). 
 
Fig. 7. TRUS of different prostatic cysts. (A) Axial TRUS of a utricle cyst; the cyst is midline 
and intraprostatic. (B) Sagittal TRUS of Mullerian duct cyst; the cyst is midline is midline 
with supraprostatic extension. (C) Axial TRUS of bilateral seminal vesicles cysts in a patient 
with obstructive azospermia. (D) Axial TRUS shows an acquired intraprostatic cyst in the in 
the right part of adenoma of benign prostatic hypertrophy 
Chronic prostatitis may be infective as a complication of acute prostatitis or noninfective 
secondary to congestion of the prostate or urinary reflux into the prostate resulting in 
inflammatory or fibrotic reaction or both within the prostate. Chronic prostatitis has varied 
sympthomatology and lack of physical signs. The diagnosis currently rests on the finding of 
excessive leukocytes in prostatic secretions. Sonographic findings include high density 
echoes, mid range echoes, echo-lucent zones, ejaculatory duct calcifications, capsular 
irregularity, capsular thickening and periurethral zone irregularity (Fig. 8 A&B). The 
sensitivity and specificity of these signs are low (Doble & Carter, 1989) 
Prostatic abscesses have been reported in an older age group due bladder outlet obstruction 
and urinary tract infection. Iatrogenic prostatic abscess have been reported after biopsy or 
instrumentation. Half of the patients presenting in acute retention and half presenting with 
irritative voiding symptoms. Of the patients 40% have fever, 25% have associated 
epididymo-orchitis. On examination, the majority showed enlarged prostate but only 20% 
present with the classic signs of prostatic fluctuance and tenderness on DRE (Sohlberg et al., 
1991). Abscess can be identified as irregular hypoechoic area containing diffuse mid-range 
echoes within an enlarged gland (Fig. 8 C). Once identified, the lesions may be aspirated 
transperineally under ultrasound control (Doble & Carter, 1989). 
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Fig. 8. (A) TRUS of a patient with chronic prostatitis shows calcification of periurethral 
tissue. (B) TRUS of another patient with chronic prostatitis shows calcification of peripheral 
zone. (C) TRUS of a case of prostatic abscess with a relatively thick wall and echogenic fluid 
content. (D) TRUS of a patient with granulomatous prostatitis shows multifocal hypoechoic 
lesions in the peripheral zone mimicking prostatic cancer 
The exact aetiology of granulomatous prostatitis remains undetermined. It is thought to be 
due to ductal obstruction and ectasia with subsequently extravasation of luminal contents 
into the glandular stroma. In most patients, these changes are thought to be idiopathic but in 
others, it can be also linked with specific infecting agents (tuberculosis, schistosomiasis, and 
fungi). In patients with granulomatous prostatitis, the prostate is usually firm, nodular or 
indurated on DRE, PSA may be elevated. Patients may present with symptoms of outflow 
tract obstruction, acute retention or urinary infection. Sonographic findings are single or 
multiple areas of low echogenicity in the peripheral zone (Fig. 8 D) or heterogeneous 
echotexture of the gland. The hypoechoic areas are indistinguishable from carcinoma and 
diagnosis must be established by biopsy (Clements et al., 1993). 
5.3 Prostatic calcifications and calculi 
Primary prostatic calculi develop in the prostatic ducts and acini. They are usually multiple 
and small (1-5mms). Secondary dystrophic calcifications are associated with infection, 
obstruction, necrosis in a prostatic adenoma or radiation therapy. They are usually larger 
and more irregular than primary calculi. It needs to be emphasized that dystrophic prostatic 
calculi are not precancerous (Hricak, 1990). Sonographically calcifications appear as bright 
echogenic foci with or without posterior acoustic shadowing. Calculi can be seen within the 
seminal vesicles, vassal ampulae or ejaculatory ducts (Fig. 9). 
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Fig. 9. (A) TRUS shows multiple flecks of calcifications seen in both seminal vesicles (SV) 
and vassal ampulae. (B) TRUS shows bilateral ejaculatory ducts calculi (arrow heads) in a 
patient with obstructive azospermia 
 
Fig. 10. (A) & (B) TRUS of BPH shows bilobed adenoma causing compression and flattening 
of the PZ. (C) TRUS of another case of BPH shows calcified surgical capsule separating the 
adenoma from the PZ. (D) TRUS of another patient with BPH shows large bilobed adenoma 
separating from the flattened PZ by hypoechoic surgical capsule 
5.4 Benign prostatic hyperplasia 
Benign prostatic hyperplasia (BPH) is rarely seen in males less than 40 years of age. It affects 
50 to 70% of men older than 60, and 80 to 85% of men older than 80 years. BPH begins in the 
inner region of the prostate adjacent to the urethra. BPH may be diffuse or focal; forming 
prostatic adenoma. The normal prostatic tissue is displayed caudally and posteriorly to form 
the surgical capsule (Mc Neal, 1983). Ultrasound is the primary imaging modality for 
evaluation of the aging men with known or suspected BPH. By transabdominal US prostatic 
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size, weight, shape and intravesical extent can be determined. Uncomplicated BPH usually 
produce a diffusely – altered inhomogenous echotexture, but distinct nodular enlargement 
cannot be differentiated from the surrounding gland (Fig. 5). Residual urine and bladder 
volume can be measured by the same formula used for estimating prostatic size 
(volume=0.52 x d1 x d2 X d3. Upper tract changes secondary to BPH are best evaluated 
using abdominal US. TRUS provides the best cross-sectional anatomy of the prostate and it 
is more accurate than transabdominal US to assess volume of the prostate and adenoma. 
BPH has a varied echotexture but is usually homogenous solitary or multiple adenomas 
(hyperplastic nodules) may be imaged, confined or extending outwards from the central 
gland often compressing the peripheral zone (Fig. 10). Although symmetry is the rule 
asymmetrical increase in size, especially near the bladder neck are common. Cysts, 
calcifications, prostatitis, infarctions and carcinoma may be coincident with BPH. The thick 
surgical capsule interposed between the central and peripheral gland can be appreciated. 
(Naryan & Foster, 1991). 
5.5 Prostatic cancer 
Carcinoma of the prostate is the most common human cancer, found at autopsy in 30% of 
men at age 50, 60% of men at age 80 – 90 up to 100% in those over age 90. It is now the 
second most common cancer in men. Pathological evidence of prostate cancer is found in  
10-20% of patients undergoing surgery for BPH. 68% of prostatic carcinomas originate in the 
PZ, 24% in the TZ, and 8% in the CZ. Carcinoma of the prostate is often adenocarcinoma 
with varying grades of differentiation in 95% (Mc Neal, 1983). Unlike lung and colon cancer, 
prostatic cancer is predominantly latent. The patient may present with the symptoms and 
signs of prostatism and occasionally haematuria. It has been speculated that prostatic cancer 
disseminates first by invading into the periprostatic tissues, then by lymphatic embolization, 
and finally by hematogenous dissemination. Prostatic cancer can also spread by direct local 
invasion and through vascular and lymphatic channels. Seminal vesicle invasion almost 
always results from direct spread of the tumor into the ejaculatory duct while crossing 
inside and prostate. The primary field of lymphatic drainage of the prostate includes the 
perivesical, hypogastric, obturator, presacral and preciatic lymph nodes. The obturator 
nodes are the commonest site of involvement (Mc Laughlin et al., 1976). Osseous metastases 
are present in about 85 percent of patients dying of prostatic cancer. Osseous metastases 
involve the cancellous bone, altering the normal internal architecture with proliferating 
osteoblasts and new bone formation. The commonest sites for visceral metastases from 
prostatic cancer lung, liver and adrenal gland, but virtually any organ may be involved. 
Pulmonary metastases, occurring in 25 to 38 percent of patients dying of prostatic cancer. 
Metastases to the central nervous system usually occur in the meninges and may be 
clinically silent. Other neurogenic manifestations of prostatic cancer include organic brain 
syndrome, raduculopathy, and paraneoplastic syndromes (Jacobs, 1983). 
5.5.1 Detection of prostate cancer 
TRUS is useful for early detection of prostate cancer, guided biopsy, local staging, and 
follow up after treatment. Its role in screening of asymptomatic men is still controversial. 
(Clements et al., 1993).The first step in any sonographic examination of the prostate should 
be to gain an overall impression of the gland’s shape and size. An irregular asymmetric 
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gland often signals malignancy even in the absence of the identifiable lesion. Even small 
prostatic cancer often alters the shape of the prostate. Distortion or bulging of the posterior 
boundary of the prostate is suggestive of the presence of cancer. Lateral distortion is of less 
significance because hyperplastic nodules of the TZ cause considerable asymmetric bulging. 
In advanced cancer, discontinuity of the capsule or seminal vesicles irregularity often can be 
seen (Shinohara et al.., 1989).  
Prostate cancer has different echotexture; it may be hypoechoic, isoechpic or hyperechoic 
(Fig. 11). Most cancers consist of a dense mass of cells which destroys the normal glandular 
structure. The malignant tissue contains few sonographically detectable interfaces and 
therefore appears hyperechoic region in relation to the adjacent normal tissue. The most 
common feature of all visible cancer is a central hypoechoic region relative to the peripheral 
zone of the normal prostate. The margins of the tumor all ill defined as the malignant cells 
invade between normal prostatic acini (Shinohara et al., 1989). The hypoechoic tumors 
represent 70-75% of prostate tumors (Hamper & Sheth, 1993). Approximately 30-35% of 
clinically detected prostate cancer cannot be distinguished from the normal surrounding 
prostatic tissue and is termed isoechoic. Several features may contribute to cancer being 
undetectable by US: tumor size, grade, location, and stage, technique of the study, 
equipment used and the experience of the operator. Absence of the normal margin between 
the PZ and TZ in a rounded prostate should alert the sonographer to the possibility of a 
large infiltrating tumor. Also, a palpable abnormality in the presence of an apparently 
normal US scan should be biopsied to avoid missing an isoechoic cancer (Shabsigh et al., 
1989). In case of presence of large adenoma of BPH, the PZ is compressed. So, it is less easy 
to detect a PZ cancer (Shinohara et al., 1989). Hyperechoic tumors are rare. Prostatic calculi 
that have been engulfed by cancer may account for a mixed echogenic pattern. Hyperechoic 
foci within the tumor correspond pathologically to comedonecrosis and calcification within 
highly undifferentiated anaplastic tumors or unusual deposits of intraluminal crystalloid 
secretions. 
The sonographic appearance of early prostate cancer is not specific. The positive predictive 
value for a hypoechoic focal lesion to be cancer has ranged from 0% to 50%. Overall, the 
incidence of malignancy in US suspicious lesion is 20% to 255 (Hamper & Sheth, 1993). 
Information from US-guided biopsy of the prostate has shown that many suspicious areas 
seen on TRUS do not correspond to cancer: negative biopsy rated of 58 to 70.8% has been 
reported (Shabsigh et al., 1989). There is a big list of differential diagnosis of intraprostatic 
hypoechoic lesions. First anatomic structures as periurethral tissue, ejaculatory duct 
complex, periprostatic veins and neuovascular bundles. Second are benign prostatic 
diseases as hyperplastic nodule (stromal types), prostatitis, abscess, cysts and hematoma. 
Lastly sonographic artifacts as inappropriate use of the focal range of transducer, acoustic 
shadowing, reverberation artifacts and edge effect (Shinhara et al., 1989). Mc Neal and 
associates have emphasized the importance of measurement of the volume of prostate 
cancer as a determinant of pathologic stage and prognosis. They described a strong 
association between tumor volume and the incidence of extracapsular extension and lymph 
node metastases (Mc Neal et al., 1986). Estimation of tumor volume by TRUS is often 
inaccurate for two reasons. Tumor size is usually underestimated, as the tumor tends to 
infiltrate invade between normal prostatic tissues. So, the margin of the tumor may 
therefore be indistinguishable from normal prostate. Second is prostate cancer is often 
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multifocal. So, U.S underestimates the maximum diameter of a focus of cancer by an 
average of 4.2 mm (Shinohara et al., 1989). 
 
Fig. 11. TRUS of four different patients with prostate cancer. The carcinoma appears as  focal 
hypoechoic area (arrow head) in the right PZ (A), diffuse hypoechogenicity of the whole 
gland (B), focal hyperechoic area (arrow head ) in the posterior PZ (C) and focal hypoechoic 
area (arrow) in the central gland (D) 
5.5.2 Extra capsular extension of prostate cancer  
Prostate cancer spreads locally through pathways of least resistance. The areas of local 
spread include the invaginated extraprostatic area around the ejaculatory duct to the 
seminal vesicles, at the apex where the capsule is deficient, areas of capsule penetration by 
superior and inferior neurovascular bundles. The prostatic capsule usually cannot be 
distinguished sonographically from the prostatic parenchyma. Consequently, the continuos 
hyperechoic border around the normal prostate, (usually referred as the “capsule”), is 
actually represents the acoustic interface between the prostate and the periprostatic fat 
(Scardino et al., 1989). Sonographic signs of capsular penetration include bulge or 
irregularity of the prostate contour and disruption or discontinuity of the echogenic 
periprostatic boundary echo (Hamper & Sheth, 1993). Spread of the cancer to the 
neurovascular bundle is suspected if the tumor is close to the posterolateral aspect of the 
prostate with irregularity of the contour at this region as well as interruption of the 
echogenic periprostatic boundary echo. TRUS is able to detect neurovascular involvement 
with sensitivity of 66% and specificity of 78% (Fig. 12 and 13). 
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Fig. 12. Two different patients with right and left lateral extracapsular extension (arrows) 
 
Fig. 13. A case of prostate cancer with left posterolateral extension through the 
neurovascular bundle (arrows) 
The pattern and extent of seminal vesicle invasion vary widely. Type I is the most common 
pattern. It shows invasion along the ejaculatory ducts into the seminal vesicle. Type II is the 
second most common pattern. The invasion of seminal vesicle occurs from a tumor that 
penetrates the capsule and invades the seminal vesicles in continuity. Type III is the least 
common pattern, where small isolated foci of tumor in the seminal vesicles. The 
sonographic criteria for seminal vesicles invasion have traditionally been described as 
asymmetry in size, irregularity in outline, atrophy and distension, but the validity of these 
signs has rarely been substantiated by surgical or pathological staging (Shinohora et al., 
1988). The accuracy of detection seminal vesicle invasion using sonography is 86% (Terries 
et al., 1990). The apex of the prostate must be carefully assessed sonographically to detect 
involvement of the rhamoboid area. This area bounded by the prostate proximally, the 
rectourethralis muscle distally, the membranous urethra anteriorly and the rectum 
posteriorly. It is best demonstrated by TRUS on the sagittal view. TRUS has no role in nodal 
staging. Also, it had limited role in detection of invasion of neighboring tissue, e.g. bladder, 
rectum and muscles of the pelvic side wall. These disadvantages of TRUS can be explained 
by its limited field of view (Scardino et al., 1989).  
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5.5.3 Response to treatment of prostate cancer 
After treatment by ochidectomy and hormonal therapy, the gland becomes smaller and 
assumes a more circular shape. Most of the decrease in volume occurred within the first 
three months. A variable series of changes in the US appearance of the gland may be seen. In 
some patients, the area of abnormal echogenicity may persist. In others, it disappears. The 
integrity of the capsule may appear to be resorted in patients with previous capsule breech. 
It may be extremely difficult to demonstrate U.S whether the active cancer is still present or 
not (Clements et al., 1989). Following radiotherapy for cancer, the prostate becomes small 
and echogenic. Anechoic or hypoechoic lesions following radiotherapy frequently represent 
persistent cancer and the positive predictive value of such lesions for cancer is 91%. Most 
foci of cancer with marked radiation effect tend to be isoechoic. The non malignant prostate 
tissue generally retains its normal echogenic appearance after irradiation. Lesions over 5mm 
in the diameter persisting for 12 months following radiotherapy are suspicious of 
malignancy and should be biopsied (Egawa et al., 1991). A decrease in total prostate volume 
is not a reliable indicator of prognosis as normal and malignant prostatic tissue will shrink 
in response to radiotherapy. Measuring PSA is probably more useful in the follow up of the 
prostate cancer (Richards, 1992). After radical retropubic prostatectomy (for clinically non 
invasive prostatic cancer), the patients are routinely followed up at periodic interval with 
DRE and measuring PSA. Elevation of PSA above the female range indicates either local 
progression, recurrence of distant metastases. Post-operative mature fibrotic tissue at the site 
of operation is difficult of distinguish form recurrent tumors by means of TRUS. The main 
value of TRUS in case of presence of post operative palapable mass may be in accurate 
positioning of the biopsy needle about the vesico-urethral anastomosis (Wasserman et., 
1992). 
6. Ultrasound guided prostatic biopsy  
The most important role for TRUS is to provide visual guidance for biopsy. Approximately 
25% to 30% of cancers are isoechoic, random biopsies of the PZ, in addition to sampling all 
suspicious lesions should be done. In the technique of random prostatic biopsies, multiple 
samples are taken from different parts of the gland mainly apex, mid gland and base 
bilaterally (Hamper & Sheth 1993). In general, TRUS guided prostate needle biopsy should 
be performed in men with an abnormal DRE, an elevated PSA (>4.0 ng/ ml) or PSA velocity 
(rate of PSA change) >0.4 to 0.75ng/ ml/ yr. Also, men who were diagnosed with high-grade 
prostatic intraepithelial neoplasia (PIN) or atypia on a previous prostate needle biopsy 
should undergo a repeat biopsy 3 to 12 months later. Less commonly agreed upon 
recommendations for TRUS guided prostate needle biopsy include, age-specifi c PSA 
elevation, low percentage free PSA (< 22% to 25%), and prostate specifi c antigen density 
(PSAD) > 0.15, which is a measure of the amount of PSA relative to the overall prostatic 
volume (Hamper & Sheth 1993).US- guided prostate biopsies can be performed either 
transperineally or transrectally. 
Transperineal approach is the first way described for US-guided prostate biopsy in 1981. 
The probe is fixed to a stabilizing biopsy stand. The perineum should be infiltrated local 
anesthetic. The entire gland is inspected and once a suspected area is identified, the biopsy 
needle is inserted and the track of the needle is monitored on the viewing screen. When the 
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needle tip approaches the area to be biopsied, the needle is positioned so that the cutting 
section can be passed through the abnormal area under visual guidance (Muldoon & 
Resnick, 1989). The drawbacks of transperineal U.S guided biopsy are difficult needle due to 
relatively long transperineal needle path, it is time consuming procedure, and patients 
tolerate the procedure poorly because of perineal pain and side effects of local anaesthesia. 
(Clements et al., 1993). Transperineal approach is preferable if prostate abscess or 
inflammatory disease is suspected. 
Transrecta approach was first described in 1987, since then, this technique has been 
described as a superior method of performing a core biopsy of the prostate (Weaver et al., 
1991). The transrectal approach offers the advantage of a shorter needle with easier needle 
placement, and quicker and relatively painless procedure. Local anesthesia is not required 
and it is done on an out-patients basic (Clements et al,. 1993). Hodge et al reported that 
systematic sampling of the prostate guided by TRUS improved the detection rate of prostate 
cancer over merely sampling hypoechoic or other lesions. By taking sextant biopsies from 
the mid lobe (parasagittal) of each side of the prostate at the apex, middle, and base (Fig. 14), 
the cancer detection rate was superior to lesion-directed biopsies (Hodge et al., 1989). This 
technique was accepted over the time as the standard of care and helped to emphasize that 
TRUS was more useful for biopsy than for imaging. In the current PSA era, though, most 
men who are undergoing prostate biopsy do not have palpable abnormalities or hypoechoic 
lesions This has lead investigators to question the sampling adequacy of the standard 
sextant prostate biopsy template and to propose alternate “extended pattern”  biopsy 
schemes to improve prostate cancer detection. The alternate prostate biopsy templates aim 
to improve sampling of the prostate by either increasing the number of core biopsies taken 
and/ or by directing the biopsies more laterally to better sample the anterior horn (Chen et 
al, 1999, Naughton et al., 2000). During biopsy, the puncture path is shown on the monitor 
as electric dotted line. The probe should be positioned so that the puncture path passes 
through the designated area. Without moving the probe, the needle is introduced through 
the needle guide and the needle tip is positioned proximal to the suspicious area. A trigger 
action biopsy gun is used to obtain a core specimen in an instance once the biopsy needle in 
place. The biopsies performed while the biopsy needle is directed parallel to the transducer 
in the sagittal plane so the needle seen as an echogenic linear structure approaching the 
suspicious area, instead of an echogenic dot in the axial plane (Lee et al., 1988).  
 
Fig. 14. Systematic TRUS –guided biopsy of the upper (A), middle (B) and lower (C) parts of 
the lateral regions peripheral zone (arrowheads) 
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7. Role of new ultrasound techniques in diagnosis of prostate cancer  
Conventional gray-scale US has low sensitivity and specificity and is mainly used for 
guiding systematic prostate biopsies. With the development of new US techniques, such as 
three dimensional US color and power Doppler US, the use of US contrast agents and 
elastography, the role of US for prostate cancer detection has dramatically improved. 
7.1 Three dimensional (3D) US of the prostate 
It gives views of the prostate in the 3 orthogonal planes; sagital, transverse and coronal and 
in any other oblique planes (Fig. 15). The detection rates of prostate cancer were significantly 
improved with 3D- TRUS. Also it may improve the biopsy yield by determining appropriate 
sites for target and systematic biopsies (Cool et al., 2008, Shen et al., 2008). With 3D imaging, 
spatial relationships much clearer, so radiologist/ urologist can better assess the extent of 
disease. It may make it easier to determine whether the “prostate capsule”  has been 
penetrated to detect possible extra-capsular tumor extension which is a key factor in staging 
of prostate cancer. It provides valuable information to plan for alternative therapies, like 
radiotherapy of the prostate and robotic prostatectomy. The 3D images are saved and they 
can be reviewed as many times as needed. Diagnosis can be achieved by retrieving the 
saved images which is most convenient for the operator and patient, leading to faster 
patient turnaround (Liang et al., 2010, Bax et al., 2008). 
 
Fig. 15. 3D images of a prostate with cancer. The image has been ‘sliced’ to reveal a 
hypoechoic lesion in the right side of the PZ (arrowhead) proved to be a cancer  
7.2 Color Doppler sonography of the prostate 
Color Doppler TRUS (CD-TRUS) has been applied to evaluate the vascularity within the 
prostate and the surrounding structures. Preliminary studies demonstrated increased flow 
within or surrounding prostate neoplasm, whereas prostatitis and BPH showed a diffusely 
abnormal flow.However, the flow of focal prostatitis was not significantly different from 
cancer. By using objective measures, as resistive indices, no statistically significant 
difference was found between cancer and benign conditions (Rifkin et al, 1993). CD-TRUS 
may help in determining the site of biopsy. If the level of PSA is elevated with DRE normal 
in one patient, the presence of hypervascular focal lesion in PZ makes the lesion the target of 
the biopsy. But, if the nodule is hypovascular, we have to biopsy the anterior part of the 
gland to detect carcinoma of the TZ. (Cornud et al., 1993). Early results have suggested that 
up to 85% of men with prostate cancers greater than 5 mm in size have visibly increased  
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flow in the area of tumor involvement. In addition, hypervascularity may be seen in patients 
with more difficult to identify, isoechoic and hyperechoic lesions (Fig. 16). Unfortunately, 
subsequent studies suggested that some prostate cancers are hypovascular. Many studies 
prove the benefits of CD-TRUS for the evaluation of prostatic disease, especially carcinoma. 
The motivation behind the application of color Doppler US is to detect tumor 
neovascularity. Cancerous tissue generally grows more rapidly than normal tissue and 
demonstrates increased blood flow; as compared to normal tissue and benign lesions. Color 
Doppler US may demonstrate an increased number of visualized vessels, as well as an 
increase in flow rate, size and irregularity of vessels within prostate cancer (Newman et al., 
1995 Littrup et al., 1995, Ismail et al., 1997) 
 
Fig. 16. (A) TRUS shows hypoechoic areas proved to be cancer (arrows). (B) Color-Doppler 
shows the same area to be of high vascularity (arrows). (C) TRUS of another patient with 
prostate cancer appears as hypoechoic area (arrows). (D) The same area appears with 
normal vascularity in color Doppler. (E) TRUS of a third patient with hypoechoic lesion of 
prostate cancer appears as hypoechoic (arrows). (F) The same lesion appears of low 
vascularity in color Doppler 
7.3 Power Doppler sonography of the prostate 
Power Doppler US is an amplitude-based technique for the detection of flow. It is more 
sensitive to slow flow and is less angle-dependent than color Doppler US. This technique 
has been less commonly applied to the assessment of prostate tumor vascularity, and there 
are few papers addressing its use. Some studies showed that prostate cancer are 
hypervascular by power Doppler (Fig. 17) so it may be useful in detection of prostate cancer 
(Inahara et al., 2004). Halpern et al assessed the value of gray-scale, color and power 
Doppler US for detection of prostatic cancer. They investigated 251 patients prior to biopsy 
and they hey concluded that power Doppler may be useful for targeted biopsies when the 
number of biopsy passes must be limited but that there is no substantial advantage of power 
Doppler over color Doppler (Halpern et al., 2000).  
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Fig. 17. (A) TRUS show a hypoechoic lesion in the right posterolateral aspect of the 
peripheral zone proved to be cancer. (B) The same area is hypervascular in power Doppler 
(C) TRUS in another patient with prostate cancer shows no evident focal lesion in grey scale 
US. (D) Power Doppler of the same patient show focal area of increased vascularity in the 
right side of the peripheral zone proved to be carcinoma by targeted biopsy 
7.4 Contrast enhanced ultrasound imaging 
Recently developed US contrast agents can improve the detection of low-volume blood flow 
by increasing the signal-to-noise ratio. Unlike radiographic contrast media, which diffuse 
into the tissue and may obscure smaller vessels, microbubble echo-enhancing agents are 
confined to the vascular lumen, where they persist until they dissolve. They have two 
important acoustic properties, first, they are many times more reflective than blood, thus 
improving flow detection. Second, their vibrations generate higher harmonics to a much 
greater degree than surrounding tissues (Forsberg et al, 1998). Bree RL and De Dreu SE 
showed that contrast enhanced color Doppler US had a sensitivity of 53%, specificity of 72%, 
and a positive predictive value of 70% in distinguishing prostate cancer from benign lesions 
in 72 patients identified by PSA screening (Bree RL & DeDreeu SE,1998). Most investigators 
showed increased sensitivity in detection of prostate cancer after the use of contrast 
enhanced US (Fig. 20). In the study of Bogers et al, they showed that sensitivity of enhanced 
images was 85% (specificity 80%) compared with 38% for unenhanced images (specificity 
80%) and 77% for conventional gray-scale transrectal US (specificity 60%) (Bogers et al., 
1999). Frauscher et al reported the value of contrast enhanced color Doppler in a prospective 
study in 90, and 230 male screening volunteers (Frauscher et al., 2001, 2002). They found that 
targeted biopsies based on contrast enhanced color Doppler detected as many cancers as 
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systematic biopsies, with fewer than half the number of biopsy cores. Halpern et al, in their 
prospective study of contrast-enhanced transrectal US in 60 patients who underwent sextant 
biopsy of the prostate concluded that the sensitivity increased from 38% at baseline to 65% 
after contrast injection (Fig. 18). However there was no significant change of specificity 
between baseline study (83%) and during contrast aging (80%) in the same study (Halpern 
et al., 2001).  
 
Fig. 18. (A) TRUS of a patient with prostate cancer show no evident focal lesions in grey 
scale US. (B) Contrast enhanced TRUS shows focal area of hypervascularity in the left side of 
the peripheral zone (arrowheads) proved to be carcinoma by targeted biopsy 
7.5 Elastography of the prostate 
Elastography or strain imaging was first described in 1991 (Ophir et al., 1991). This 
technique can be used to detect degree of stiffness of the tissues. In a pilot study done by 
Klauser et al, patients with clinically localized prostate cancer who underwent radical 
prostatectomy were examined prospectively. They found that elastography detected 28 of 32 
cancer foci (sensitivity 88%) and they concluded that elastography is a sensitive new 
imaging modality for the detection of prostate cancer (Klauser et al., 2003). Konig et al. 
evaluated elastography for biopsy guidance for prostate cancer detection in 404 men 
underwent systematic sextant biopsy. They found that in 127 of the cancer proved 151 cases 
(84.1%), prostate cancer was detected using elastography as an additional diagnostic feature. 
They concluded that it is possible to detect prostate cancer with a high degree of sensitivity 
using real-time elastography in conjunction with conventional diagnostic methods for 
guided prostate biopsies (Konig et al., 2005). Supersonic shear imaging (SSI) is a new US-
based technique for real-time visualization of soft tissue elastographic properties. Using 
ultrasonic focused beams, it is possible to remotely generate mechanical vibration sources 
radiating low-frequency, shear waves inside tissues (Bercoff et al., 2004). Athanasiou et al 
studied quantitative ultrasonographic elastography of breast lesions in 46 women. They 
concluded that SSI provides quantitative elasticity measurements, thus adding 
complementary information that potentially could help in breast lesion characterization 
with B-mode US (Athanasiou et al., 2010). Recently a preliminary study by Correas et al 
done to evaluated the feasibility of TRUS quantitative Shear Wave Elastography (SWE) for 
prostate cancer evaluation in 21 patients presenting with increased PSA values (Fig. 19). 
Elasticity measurements and ratios between nodules and adjacent parenchyma were 
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calculated. They found that signals were obtained in both the peripheral and the transition 
zones with good correlation to anatomical areas, macro-calcifications exhibited very high 
stiffness values and prostate cancer nodules exhibited a high stiffness than the adjacent 
peripheral gland. Also they noticed that peripheral adenomatous hyperplasia and focal 
prostatitis exhibited a significantly lower stiffness. They concluded that TRUS quantitative 
SWE is a feasible technique for prostate cancer evaluation. It provides additional 
information about stiffness of nodules localized in the peripheral zone (Correas et al., 2011). 
These preliminary results are encouraging but a larger multicentric evaluation remains 
necessary. 
 
Fig. 19. (A) TRUS of a normal homogeneous PZ. (B).TRUS-SWE shows homogeneous blue 
coding of PZ (arrow) indicating its soft texture. (B) TRUS of another patient shows a 
hypoechoic area in left PZ proved to be carcinoma (atypical pattern). (D) TRUS-SWE of the 
same patient shows the focal area has blue coding (arrow) indicating its soft texture. (E) 
TRUS of another patient with a hypoechoic nodule in the left PZ proved to be carcinoma 
(arrow). (F) TRUS-SWE of the same patient shows a strong increase in stiffness values of the 
focal area (red) with a ratio of 2.8 compared to the surrounding PZ (typical pattern) 
(adapted from Correas et al 2011) 
8. Role of ultrasound in prostate cancer treatment 
Recent interest in focal therapy for localized prostate cancer has been driven by downward 
stage migration, improved biopsy and imaging techniques. Several techniques have 
potential for focal ablation of prostate cancer. 
8.1 TRUS-guided cryotherapy for prostate cancer 
Cryotherapy is tissue ablation by local induction of extremely cold temperatures. The first 
use cryoablation in urological disorders started in the 1960s for management of benign 
prostatic hyperplastic tissue (Gonder et al., 1966). This was followed shortly thereafter by 
the treatment of prostate cancer via an open perineal approach (Fig. 20). The major 
impediment to early acceptance of the modality, however, was the inability to accurately 
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monitor cryoprobe placement and ice-ball formation. Major advances in the past 20 years, 
which have reinvigorated investigation into the use of cryotherapy for prostate cancer, have 
included the use of TRUS monitoring of probe placement and freezing (Onil et al,1993). A 
significant recent development was the introduction of cryotherapy probes that use argon 
gas rather than liquid nitrogen (De La Taille et al., 2000). Outcomes have now been reported 
as late as 7 years following treatment of prostate cancer and seem to compare favorably with 
contemporary series of patients who receive radiation therapy (Bahn et al., 2002 ). Marberger 
et al reported that cryotherapy has been used for some time as a form of first-line therapy 
for complete ablation of the prostate or and as a second-line therapy for local recurrence 
after radiotherapy (Marberger et al., 2008). 
 
Fig. 20. (A) TRUS of the prostate illustrating placement of the cryoprobes and urethral-
warming catheter. (B) TRUS of the prostate during cryoablation showing the ice ball, 
growing posteriorly, is echodense and casts a dark acoustic shadow. (C) The ice ball extends 
posteriorly to include the whole prostate tissue. Transrectal sonogram of the prostate 
illustrating placement of the cryoprobes and urethral-warming catheter 
8.2 High-intensity focused ultrasound (HIFU) 
HIFU is one of the newer methods that have been developed to treat early stage prostate 
cancers. High energy is delivered to the affected area by ultrasound, this result in the 
targeted cancerous cells heating up and being destroyed. Using extracorporeal HIFU, 
temperatures of greater than 60°C can be achieved in the target tissue. The prostate can be 
easily treated with this modality via a transrectal probe. Gelet et al pioneered the use of 
transrectal HIFU in the treatment of localized prostate cancer. Prostates smaller than 40 mL 
or those with an anteroposterior diameter of less than 5 cm are best suited for this treatment. 
During the procedure, the whole gland is treated. They reported that 78% of low-risk 
patients were disease-free and had negative biopsy results at an actuarial 5-year follow-up 
(Gelet et al., 2004). Some of the advantages of HIFU are that it is able to be repeated if cancer 
reappears; it can destroy cancer in targeted areas of the prostate without destroying other 
areas of the prostate; and it can be given to patients who may not be able to take other forms 
of prostate treatment such as brachytherapy. Marberger et al reported that HIFU has been 
used widely in Europe for complete ablation of the prostate, especially in elderly men who 
are unwilling or unable to undergo radical therapy. For low- or intermediate-risk cancer, the 
short- and intermediate-term results have been acceptable. Focal use of HIFU should reduce 
the adverse sexual and urinary side effects of whole gland ablation (Marberger et al., 2008).  
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8.3 Vascular-targeted photodynamic therapy (VTFT) 
VTFP is a minimally invasive ablative treatment for localized prostate cancer and may 
represent a preferred option for men with low-risk disease who want to balance the risks 
and benefits of treatment. (Lepor, 2008). VTPT has been used for whole gland ablation of 
locally recurrent cancer after radiotherapy and for focal ablation of previously untreated 
cancer. In combination with a new, systemically administered photodynamic agent, laser 
light is delivered through fibers introduced into the prostate under TRUS. This technique 
does not heat the prostate but destroys the endothelial cells and cancer by activating the 
photodynamic agent. Damage to surrounding structures appears to be limited and can be 
controlled by the duration and intensity of the light. (Marberger et al., 2008). 
8.4 TRUS-guided prostate brachytherapy  
Brachytherapy is an effective treatment for localized prostate cancer with high patient 
tolerability and acceptable morbidity outcome data. It delivers a high dose of radiation to a 
small target volume of tissue, minimizing radiation side-effects to adjacent structures. 
Brachytherapy is an alternative to radical surgery and external beam radiotherapy and can 
be delivered in two different ways: permanent seed implants using iodine or palladium seeds 
or using temporary removable implants with iridium wires. TRUS is essential for accurate 
imaging guidance to place the radioactive sources into the prostate (Fig. 21). Prostate 
brachytherapy data has now matured as a treatment with consistent results reported from 
major centers in the US and Europe (Henry et al., 2010, Battermann et al., 2008). 
 
Fig. 21. Prostate brachytherapy. (A) Transrectal ultrasound set-up: transverse image of the 
prostate with 5mm template overlay. (B) Transverse image of the prostate after seed implant 
(echogenic areas) 
9. Conclusion 
One of the major advances that have greatly improved our understanding of prostatic 
diseases is the development of sonography especially TRUS. It is considered the first 
imaging modality in diagnosis of prostate diseases. Improvement of the application of the 
new advances in US for the detection and clinical staging of prostate cancer is promising. 
TRUS-guided procedures are now widely used in diagnosis and treatment of prostate 
cancer. Radiologists and urologists should be well trained in the application of these new US 
techniques and should therefore play an important role in the management of prostate 
cancer in the future. 
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